MedaSync
$1.6M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
MedaSync is currently valued at $11.2M as of August 8, 2025. The company has raised a total of $3.6M in funding.
Capital Efficiency
With a capital efficiency ratio of 3.08x, MedaSync has achieved a valuation that is 3.08 times the total capital raised. This metric indicates strong capital efficiency and effective deployment of investor funds.
Investment Perspective
MedaSync's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is MedaSync Worth in 2025?
As of 2025, MedaSync is valued at $11.2M, based on the company's Later Stage VC funding round in August 8, 2025. This valuation positions MedaSync as one of the leading private companies in the sector.
MedaSync Valuation History
MedaSync's funding history demonstrates steady growth and investor confidence.
How MedaSync Valuation is Determined
Private company valuations like MedaSync's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
MedaSync Valuation FAQs
Is MedaSync profitable?
MedaSync has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does MedaSync's valuation compare to competitors?
MedaSync is valued at $11.2M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will MedaSync IPO?
MedaSync has not announced plans for an initial public offering. Until an IPO, investors can access MedaSync shares through secondary market platforms.